Deals

Deals  ·  Weekly Digest -04 July to 10 July
Biocytogen and Whitehawk Therapeutics enter global collaboration for bispecific antibody ADC development

Weekly Digest – July 2026 Weekly Digest – July 2026 29 June 2026: Enhertu approved in the EU as the first tumor-agnostic HER2-targeted ADC for previously treated HER2 positive metastatic Solid tumors The European Union has approved Enhertu as the […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest -04 July to 10 July
RyboDyn awarded USD 1.3 million department of war grant to advance novel antibody therapies for lung cancer

Weekly Digest – July 2026 Weekly Digest – July 2026 29 June 2026: Enhertu approved in the EU as the first tumor-agnostic HER2-targeted ADC for previously treated HER2 positive metastatic Solid tumors The European Union has approved Enhertu as the […]

by Sandhya Ramalingam

Continue Reading